ghk-cu hair growth study clinical trial AHK-Cu Copper Peptide (2007) — Plain-Language Summary ghk-cu hair growth clinical study
Description
After the acute repletion phase, therapy is usually transitioned to an oral maintenance multivitamin containing a physiological dose of pyridoxine (2-5 mg daily) for several weeks, along with dietary counseling to prevent recurrence
Would give more stars if I could
Tolerability (human reports): Small uncontrolled reports describe NAD+ infusions as generally tolerated, with dose-related flushing and GI effects
TB-500, on the other hand, has been linked to corneal wound research, where it appears to influence inflammatory signaling pathways and may reduce apoptosis in epithelial cells
